Skip to content
GenoLensGenoLens

DMRT1

Chr 9p24.3

doublesex and mab-3 related transcription factor 1

Aliases:
DMT1, CT154
MANE:
ENST00000382276.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Differences in sex development

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • neurodegenerative disease

    0.53
  • testicular cancer

    0.48
  • uterine corpus leiomyoma

    0.47
  • testicular germ cell tumor

    0.44
  • Uterine leiomyoma

    0.41
  • spermatogenic failure

    0.37
  • male infertility

    0.37
  • male infertility with azoospermia or oligozoospermia due to single gene mutation

    0.36
  • testicular non-seminomatous germ cell tumor

    0.32
  • testicular neoplasm

    0.32

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Doublesex- and mab-3-related transcription factor 1

Transcription factor that plays a key role in male sex determination and differentiation by controlling testis development and male germ cell proliferation. Plays a central role in spermatogonia by inhibiting meiosis in undifferentiated spermatogonia and promoting mitosis, leading to spermatogonial development and allowing abundant and continuous production of sperm. Acts both as a transcription repressor and activator: prevents meiosis by restricting retinoic acid (RA)-dependent transcription and repressing STRA8 expression and promotes spermatogonial development by activating spermatogonial differentiation genes, such as SOHLH1. Also plays a key role in postnatal sex maintenance by maintaining testis determination and preventing feminization: represses transcription of female promoting genes such as FOXL2 and activates male-specific genes. May act as a tumor suppressor. May also play a minor role in oogenesis (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.